| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 10/27/264:02 PM | -$0.52 | -$0.52GAAP | 0.0% | -58% | $34.7M | $35.5M | +2.3% | +30% | |
| Q2 '26 | 7/29/264:02 PM | -$0.56 | -$0.53GAAP | +5.4% | -36% | $31.5M | $32.0M | +1.6% | +38% | |
| Q1 '26 | 4/21/264:03 PM | -$0.48 | -$0.49GAAP | -2.1% | +47% | $27.3M | $27.6M | +1.3% | +57% | |
| Q4 '25 | 2/17/264:02 PM | -$0.39 | -$0.30GAAP | +23.1% | n/m | $31.5M | $32.1M | +2.0% | +57% | |
| Q3 '25 | 10/28/254:02 PM | -$0.43 | -$0.33GAAP | +23.3% | -48%* | $24.0M | $27.3M | +13.8% | +63% | |
| Q2 '25 | 7/29/254:02 PM | -$0.48 | -$0.39GAAP | +18.7% | — | $19.7M | $23.2M | +17.9% | — | |
| Q1 '25 | 5/6/254:02 PM | -$0.51 | -$0.93GAAP | -82.4% | -129%* | $16.2M | $17.6M | +9.2% | +36% |
n/m = not meaningful: one EPS figure is from around the IPO, before preferred stock converted and the share count settled, so the two are on different share counts.
* Q3 '25: Year-ago EPS (-1.46) was before the IPO, on far fewer shares. Restated to today's share count from SEC filings: -0.223. Q1 '25: Year-ago EPS (-2.07) was before the IPO, on far fewer shares. Restated to today's share count from SEC filings: -0.406.
GAAP = diluted EPS as filed with the SEC.